Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas-Reference-Cited by-同舟云学术

Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas

Published:2011-05-18 Issue:3 Volume:224 Page:328-333
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Wiegand Kimberly C,Lee Anna F,Al-Agha Osama M,Chow Christine,Kalloger Steve E,Scott David W,Steidl Christian,Wiseman Sam M,Gascoyne Randy D,Gilks Blake,Huntsman David G

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference10 articles.

1. ARID1A mutations in endometriosis-associated ovarian carcinomas;Wiegand;N Engl J Med,2010

2. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma;Jones;Science,2010

3. Genomic and functional evidence for an ARID1A tumour suppressor role;Huang;Genes Chromosomes Cancer,2007

4. Clinicopathological significance of loss of ARID1A immunoreactivity in ovarian clear cell carcinoma;Maeda;Int J Mol Sci,2010

5. Identification of prognostically relevant and reproducible subsets of endometrial adenocarcinoma based on clustering analysis of immunostaining data;Alkushi;Mod Pathol,2007

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromatin modifiers in endometriosis pathogenesis;Obstetrics, Gynecology and Reproduction;2024-06-08

2. Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of ARID1A Mutant Cancers;Cancer Research;2024-06-04

3. ARID1A is involved in DNA double-strand break repair in gastric cancer;Journal of Gastrointestinal Oncology;2024-06

4. Therapeutic index of targeting select chromatin complexes in human cancer patients;Current Opinion in Genetics & Development;2024-04

5. Prognostic role of transcription factorARID1Ain patients with endometrial cancer of no specific molecular profile (NSMP) subtype;International Journal of Gynecologic Cancer;2024-03-19